SPY415.87+4.42 1.07%
DIA340.44+2.91 0.86%
IXIC14,038.76+180.92 1.31%

BRIEF-EMA Says Investigation Of AstraZeneca's COVID-19 Vaccine And Thromboembolic Events Continues

· 03/16/2021 15:20
BRIEF-EMA Says Investigation Of AstraZeneca's COVID-19 Vaccine And Thromboembolic Events Continues

-

  • EMA SAYS INVESTIGATION OF COVID-19 VACCINE ASTRAZENECA AND THROMBOEMBOLIC EVENTS CONTINUES

  • EMA SAYS EVALUATION IS LOOKING AT AVAILABLE DATA RELATED TO ALL THROMBOEMBOLIC EVENTS REPORTED AFTER ASTRAZENECA COVID-19 VACCINATION

  • EMA SAYS NATIONAL AGENCIES ARE PROVIDING ADDITIONAL SUPPORT TO GATHER MISSING AND INCOMPLETE INFORMATION AS QUICKLY AS POSSIBLE

  • EMA- EMA'S SAFETY COMMITTEE WILL CONCLUDE ON INFORMATION AVAILABLE AT ITS MEETING ON 18 MARCH &ISSUE ANY NECESSARY RECOMMENDATIONS FOR FURTHER ACTION

  • EMA SAYS RAPID AND THOROUGH ANALYSIS OF THE AVAILABLE DATA AND CLINICAL CIRCUMSTANCES SURROUNDING SPECIFIC CASES IS CONTINUING

Source text : https://bit.ly/38LIjP5

Further company coverage: AZN.L


((Reuters.Briefs@thomsonreuters.com;))